Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicenter, Large Simple Trial (LST) To Compare The Cardiovascular Safety Of Ziprasidone And Olanzapine

NCT00418171 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00418171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00418171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicenter, Large Simple Trial (LST) To Compare The Cardiovascular Safety Of Ziprasidone And Olanzapine
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2002
Completion date
April 30, 2007
Enrollment
18,239 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia